Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis
- PMID: 1732336
- DOI: 10.1016/0190-9622(92)70006-2
Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis
Abstract
Background: We hypothesized that hyperplasia of papillary dermal nerves was a constant feature of prurigo nodularis.
Objective: We tested this hypothesis by examining sections from 25 cases of prurigo nodularis, 25 cases of skin lesions characterized by epidermal hyperplasia without clinical pruritus, and 22 cases of clinically pruritic dermatoses with variable degrees of epidermal response for the presence of papillary dermal nerves.
Methods: We used a standard immunohistochemical assay with an antibody to S-100 protein as a means of identification of nerves.
Results: In 24 of 25 cases of prurigo nodularis, papillary dermal nerves were identified by immunostaining. Cutaneous nerves were present in 1 of 22 cases of epidermal hyperplasia with pruritus and were absent in the papillary dermis in nonpruritic cases.
Conclusion: We conclude that hypertrophy of cutaneous papillary dermal nerves is a relatively constant feature of prurigo nodularis. The presence of papillary dermal nerves suggests a neurocutaneous component in the pathogenesis of prurigo nodularis.
Similar articles
-
Merkel cells and prurigo nodularis.J Am Acad Dermatol. 1994 Jul;31(1):86-8. doi: 10.1016/s0190-9622(94)70141-5. J Am Acad Dermatol. 1994. PMID: 7517411
-
Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis.Arch Dermatol Res. 2000 Aug;292(8):371-8. doi: 10.1007/s004030000142. Arch Dermatol Res. 2000. PMID: 10994770
-
Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining.J Dermatol Sci. 1998 May;17(1):24-32. doi: 10.1016/s0923-1811(97)00066-2. J Dermatol Sci. 1998. PMID: 9651825
-
Prurigo nodularis: a review.Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. doi: 10.1111/j.1440-0960.2005.00187.x. Australas J Dermatol. 2005. PMID: 16197418 Review.
-
The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.Eur J Pain. 2016 Jan;20(1):37-40. doi: 10.1002/ejp.767. Epub 2015 Sep 28. Eur J Pain. 2016. PMID: 26416433 Review.
Cited by
-
Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis.Front Med (Lausanne). 2022 Dec 21;9:1022889. doi: 10.3389/fmed.2022.1022889. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619628 Free PMC article.
-
Treatment-resistant prurigo nodularis: challenges and solutions.Clin Cosmet Investig Dermatol. 2019 Feb 28;12:163-172. doi: 10.2147/CCID.S188070. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 30881076 Free PMC article. Review.
-
The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo.Dermatol Ther (Heidelb). 2019 Dec;9(4):613-622. doi: 10.1007/s13555-019-00321-6. Epub 2019 Sep 11. Dermatol Ther (Heidelb). 2019. PMID: 31512177 Free PMC article. Review.
-
Ultraviolet radiation abolishes cutaneous nerve stainings with two axon-specific antibodies in guinea-pig skin.Arch Dermatol Res. 1993;284(8):460-5. doi: 10.1007/BF00373357. Arch Dermatol Res. 1993. PMID: 8507277
-
Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups.Ann Dermatol. 2021 Aug;33(4):333-338. doi: 10.5021/ad.2021.33.4.333. Epub 2021 Jul 1. Ann Dermatol. 2021. PMID: 34341634 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical